All articles by Kezia Parkins

3D printing in drug manufacturing: unlocking future possibilities

From personalised medicine to the democratisation of drug access, XIL Health founder and CEO Susan Lang believes 3D printing can bring many benefits to drug manufacturing. Here she tells Kezia Parkins more about the technology’s potential.

Approach to spur testosterone production instead of synthesis on the horizon

Current treatments for hypogonadism involve synthetic hormones or steroids which come with side effects and high abuse potential.

Coronavirus company news summary – Moderna Covid-19 booster effective against Omicron – Everest-Providence’s vaccine gets support to join WHO STV clinical trial

Coronavirus company news summary – WHO grants emergency use approval for Novavax and SII’s Covid-19 vaccine – Switzerland orders more Covid-19 vaccine doses

Coronavirus company news summary – Brazil authorises Pfizer’s Covid-19 vaccine for children – Merck’s antiviral pill for Covid-19 gains approval in Denmark

Coronavirus company news summary – Preliminary data of Sanofi-GSK Covid-19 vaccine booster shows promise – New Zealand grants provisional approval for Pfizer vaccine in children

Unmet needs: a brief history of ALS and its sparse pipeline

With an experimental treatment showing promise, Kezia Parkins charts the history of ALS and its treatments.

Vaxxinity CEO Mei Mei Hu on vaccine research and democratising health

Vaxxinity CEO Mei Mei Hu discusses her newly-formed company, its vaccine programmes and her mission to serve the underserved.